Carolinas Medical Center
Charlotte, North Carolina, 28203, United States
NCT Number: NCT04547283
This study aims to determine if a strategy of recommending prone (on stomach) positioning of patients positive or suspected positive for coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, but not mechanically ventilated, Is feasible in the inpatient setting. This study will be performed as a pragmatic pilot clinical trial to gain information relevant to the future conduct of a larger trial.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Charlotte, North Carolina, 28203, United States
Severe acute respiratory syndrome coronavirus-2, SARS-CoV-2, the virus causing coronavirus disease 2019 (COVID-19) pandemic, has rapidly led to significant morbidity and mortality worldwide, primarily through lower respiratory tract involvement progressing from hypoxemia to acute respiratory distress syndrome. Novel approaches to improving oxygenation are urgently needed to limit aerosolization concerns and resource scarcity associated with intubation and, to a lesser extent, other forms of advanced respiratory support.
Prone positioning in mechanically ventilated patients with hypoxemic respiratory failure has been associated with improvement in oxygenation and mortality in patients with acute respiratory distress syndrome (ARDS). The prone position appears to provide more uniform lung perfusion, shifting ventilation to well-perfused lung segments and recruitment of dependent atelectatic regions of lung. Physiological alterations associated with the prone position would foreseeably also apply to spontaneously breathing patients and evidence from small observational studies suggests that prone positioning in non-intubated patients is feasible associated with improvement in oxygenation. However, it remains unknown if a prone ventilation strategy is truly beneficial for non-intubated hypoxic Covid-19 patients, and this question has stimulated interest in the conduct of rigorous randomized controlled trials (RCT).
However, the awake prone strategy is a complex medical intervention with multiple implementation nuances such as adoption, feasibility, and tolerability that may affect successful conduct of a definitive RCT. In order to increase the likelihood of a successful future RCT, the investigators will conduct the APPS pilot study. The overall aim of the APPS pilot trial was to assess feasibility and important contextual factors for a large RCT to compare the clinical effectiveness of an Awake-Prone Positioning Strategy (APPS) for respiratory support versus usual care alone for hypoxic adults with Covid-19.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No clinical team recommendation, patients will remain in their natural choice of position
Clinical team guidance on prone positioning of patients
Time frame: 48 hours from eligibility
Average oxygen saturation to fraction of inspired oxygen ratio
Time frame: 48 hours from eligibility
Time spent with oxygenation saturation to fraction of inspired oxygen ratio less than 315
Time frame: 48 hours from eligibility
Highest level of supplemental oxygen required
Time frame: 48 hours from eligibility
Number of patients requiring ICU admission during study period
Time frame: through study completion, Up to 30 days
Number of patients requiring ICU admission during hospitalization
Time frame: through study completion, Up to 30 days
Number of patients who die prior to hospital discharge
Time frame: 48 hours From eligibility
Number of patients requiring intubation
Time frame: through study completion, Up to 30 days
Number of days from hospital admission to discharge
Wake Forest University Health Sciences
Other
Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19: A Pilot Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04545541
COVID-19, Coronaviridae Infections
Frederick, Maryland, United States
View Trial DetailsNCT04558476
COVID-19, Corona Virus Infection
Ottignies, Brabant Wallon, Belgium
View Trial DetailsNCT04818866
Acute Kidney Injury, COVID-19
Ann Arbor, Michigan, United States
View Trial DetailsNCT05805579
COVID-19, Coronaviridae Infections
Zaragoza, Spain
View Trial Details